Novel B-cell precursor leukemia sister cell lines, NALM-33 and NALM-34, established from a patient with acute lymphoblastic leukemia

Leukemia and Lymphoma

Volumn 35, Issue 5-6, 1999, Pages 513-526

  Matsuo, Yoshinobu ^a   Drexler, Hans G ^b   Takeuchi, Makoto ^c   Orita, Kunzo ^a  

^a HAYASHIBARA BIOCHEMICAL LABORATORIES INC   (Japan)

^b LEIBNIZ INSTITUTE DSMZ GERMAN COLLECTION OF MICROORGANISMS AND CELL CULTURES   (Germany)

^c Natl Sanat Minami Okayama Hospital   (Japan)

Author keywords

B cell precursor ALL; Cell line; Leukemia

Indexed keywords

CD19 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKINE; HLA DR ANTIGEN; IMMUNOGLOBULIN HEAVY CHAIN; MICROSOMAL AMINOPEPTIDASE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGED; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CASE REPORT; CELL PROLIFERATION; CELL STIMULATION; CELL STRUCTURE; CELL SUSPENSION; CHROMATIN; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CYTOPLASM; EPSTEIN BARR VIRUS; GENE REARRANGEMENT; GERM LINE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA CELL LINE; LYMPHOBLAST; MALE; NUCLEOLUS; PHENOTYPE; POLYMERASE CHAIN REACTION; PRECURSOR; PRIORITY JOURNAL; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0033398048     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/10428199909169616     Document Type: Article

References (30)

1. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A., Gralnick, H. R. and Sultan, C. (1976) Proposals for the classification of acute leukaemias. Br. J. Haematol., 33, 451-458.
2. Bennett, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, J. R. and Sultan, C. (1985) Proposed revised criteria for the classification of the acute leukemias: A report of the French-American-British Cooperative Group. Ann. Intern. Med., 103, 620-625.
3. First MIC Cooperative Study Group. (1986) Morphologic, immunologic, and cytogenetic (MIC) working classification of acute lymphoblastic leukemias. Cancer Genet. Cytogenet., 23, 189-197.
4. Second MIC Cooperative Study Group. (1986) Morphologic, immunologic, and cytogenetic (MIC) working classification of the acute myeloid leukemias. Cancer Genet. Cytogenet., 30, 1-15.
5. Third MIC Cooperative Study Group. (1986) Recommendations for a morphologic, immunologic, and cytogenetic (MIC) working classification of the primary and therapy-related myelodysplastic disorders. Cancer Genet. Cytogenet., 32, 1-10.
6. European Group for the Immunological Characterization of Leukemias, Bene, M. C., Castoldi, G., Knapp, W., Ludwig, W. D., Matutes, E., Orfao, A. and Van't Veer, M. B. (1995) Proposals for the immunological classification of acute leukemias. Leukemia, 9, 1783-1786.
7. Rosenfeld, C., Gounter, A., Choquet, C., Venuat, A. M., Kayibanda, B. and Pico, J. L. (1977) Phenotypic characterization of a unique non-T, non-B acute lymphoblastic leukaemia cell line. Nature, 267, 841-843.
8. Matsuo, Y and Drexler, H. G. (1998) Establishment and characterization of human B cell precursor-leukemia cell lines. Leukemia Res., 22, 567-579.
9. Homma, T., Suzuki, K., Kudo, Y., Inagawa, M., Mizuno, S., Yamaguchi, K. and Tagawa, M. (1989) Preparation and characterization of monoclonal antibodies against human myeloperoxidase. Arch. Biochem. Biophys., 273, 189-196.
10. Tsuganezawa, K., Kiyokawa, N., Matsuo, Y., Kitamura, F., Toyama-Sorimachi, N., Kuida, K., Fujimoto, J. and Karasuyama, H. (1998) Flow cytometric diagnosis of the cell lineage and developmental stage of acute lymphoblastic leukemia by novel monoclonal antibodies specific to human pre-B-cell receptor. Blood, 92, 4317-4324.
11. Seabright, M. (1971) A rapid banding technique for chromosomes. Lancet, 2, 971-972.
12. Hopert, A., Uphoff, C. C., Wirth, M., Hauser, H. and Drexler, H. G. (1993) Specificity and sensitivity of polymerase chain reaction (PCR) in comparison with other methods for the detection of mycoplasma contamination in cell lines. J. Immunol. Methods, 164, 91-100.
13. Hane, B., Tummler, M., Jager, K., Schleithoff, L., Jansen, J. W. G. and Drexler, H. G. (1992) Differences in DNA fingerprints of continuous leukemia-lymphoma cell lines from different sources. Leukemia, 6, 1129-1133.
14. Yamada, M., Hudson, S., Tournay, O., Bittenbender, S., Shane, S. S., Lange, B., Tsujimoto, Y., Caton, A. J. and Rovera, G. (1989) Detection of minimal disease in hematopoietic malignancies of the B-cell lineage by using third-complementarity-determining region (CDR-III)-specific probes. Proc. Natl. Acad. Sci. USA, 86, 5123-5127.
15. Matsuo, Y., MacLeod, R. A. F., Kojima, K., Kuwahara, K., Sakata, A., Drexler, H. G., Nishizaki, C., Fukuda, S., Inoue, Y., Sezaki, T., Sakaguchi, N. and Orita, K. (1997) A novel ALL-L3 cell line, BALM-16, lacking expression of immunoglobulin chains derived from a patient with hypercalcemia. Leukemia, 11, 2168-2174.
16. -) from acute leukemia. Leukemia, 10, 700-706.
17. Hu, Z-B., Ma, W., Uphoff, C. C., Metge, K., Gignac, S. M. and Drexler, H. G. (1993) Myeloperoxidase: Expression and modulation in a large panel of human leukemia-lymphoma cell lines. Blood, 82, 1599-1607.
18. Ferrari, S., Mariano, M. T., Tagliafico, E., Sarti, M., Ceccherelli, G., Selleri, L., Merli, F., Marni, F., Donelli, A. and Torelli, U. (1988) Myeloperoxidase gene expression in blast cells with a lymphoid phenotype in cases of acute lymphoblastic leukemia. Blood, 72, 873-876.
19. Stass, S. A. and Mirro, J. Jr. (1986) Lineage heterogeneity in acute leukaemia: Acute mixed lineage leukaemia and lineage switch. Clin. Haematol., 15, 811-827.
20. Cory, S. (1986) Activation of cellular oncogenes in hematopoietic cells by chromosome translocation. Adv. Cancer Res., 47, 189-234.
21. Akasaka, T., Yonetani, N., Akasaka, H., Ohno, H. and Okuma, M. (1998) Detection of t(8:14)(q24:q32) by polymerase chain reaction for long DNA targets: a report of two patients with B-cell Non-Hodgkin's lymphoma. Int. J. Hematol., 67, 75-79.
22. Korsmeyer, S. J., Hieter, P. A., Ravetch, J. V., Poplack, D. G., Waldmann, T. A. and Leder, P. (1981) Developmental hierarchy of immunological gene rearrangements in human leukemic pre-B cell. Proc. Natl. Acad Sci. USA, 78, 7096-7100.
23. Tonegawa, S. (1983) Somatic generation of antibody diversity. Nature, 302, 575581.
24. Blackwell, T. K. and Alt, F. W. (1989) Mechanism and developmental program of immunoglobulin gene rearrangement in mammals. Annu. Rev. Genet., 23, 605-636.
25. Alt, F. W., Blackwell, T. K., DePinho, R. A., Reth, M. G. and Yancopoulos, G. D. (1986) Regulation of genome rearrangement events during lymphocyte differentiation. Immunol. Rev., 89, 5-30.
26. Novobrantseva, T. I., Martin, V. M., Pelanda, R., Muller, W., Rajewsky, K. and Ehlich, A. (1999) Rearrangement and expression of immunoglobulin light chain genes precede heavy chain expression during normal B cell development in mice. J. Exp. Med., 189, 75-87.
27. Ohyashiki, K., Miyauchi, J., Ohyashiki, J. H., Saito, M., Yaguchi, M., Inatomi, Y., Nakazawa, S., Wada, H., Mizutani, S., Matsuo, Y. Minowada, J. and Toyama, K. (1993) Interleukin-7 enhances colony growth and induces CD20 antigen of a Ph+ acute lymphoblastic leukemia cell line OM9;22. Leukemia, 7, 1034-1040.
28. Estrov, Z., Talpaz, M., Zipf, T. F., Kantarjian, H. M., Ku, S., Ouspenskaia, M. V., Hirsch-Ginsberg, C., Huh, Y., Yee, G. and Kurzrock, R. (1996) Role of granulocyte-macrophage colony-stimulating factor in Philadelphia (Ph1)-positive acute lymphoblastic leukemia: Studies on two newly established Ph1-positive acute lymphoblastic leukemia cell lines (Z-119 and Z-18). J. Cell Physiol., 166, 618-630.
29. Estrov, Z., Talpaz, M., Ku, S., Harris, D., LaPushin, R., Koller, C. A., Hirsh-Ginsberg, C., Huh, Y., Yee, G. and Kurzrock, R. (1996) Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. Leukemia, 10, 1534-1543.
30. Matsuo, Y., Sugimoto, A., Kuwahara, K., Watanabe, Y., Sakata, A., Sakaguchi, N., Sagawa, K. and Orita K. (1998) Monoclonal antibody NU-B1 reacts with novel antigen on human B cells in mantle and marginal zones distinct from known CD molecules. Tissue Antigens, 52, 422-429.